Contact
Please use this form to send email to PR contact of this press release:
Sarcomatrix Therapeutics and Celito Tech Announce Strategic Collaboration to Advance S-969 to the Clinic
TO:
David R Craig
Sarcomatrix Therapeutics Corp.
+1 415-246-3311